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The purpose of this study was to characterize the severe postoperative irreversible visual
loss induced by optic neuropathy in some children with a brain tumor. The computerized
database (2003–2008) of a neuro-ophthalmology service of a major pediatric tertiary center
was reviewed for all children with severe irreversible visual loss (counting ﬁngers or less)
due to brain-tumor-related optic neuropathy at their last follow-up examination. Data on age,
gender, etiology, initial symptoms, and signs, visual acuity before and after surgery and at
last examination, neuroimaging ﬁndings, and treatment were collected. Of 240 children,
198 were operated. Of those, 10 (5%, 5 boys and 5 girls) met the study criteria. Data for
the initial visual examination were available for eight children: one had binocular blindness
(uncertain light perception, counting ﬁngers); three had monocular blindness already at
diagnosis (no light perception, counting ﬁngers, no ﬁxation); three had 6/60 vision in the
worse eye; and one had good vision bilaterally (6/10). Four children had direct optic nerve
compression, four papilledema, and three gliomas. Four children (40%; with craniopharyn-
gioma, pineal germinoma, or posterior fossa tumor) exhibited a rapid deterioration in vision
after tumor depression (one direct optic nerve compression and three increased intracra-
nial pressure); two had monocular visual loss postoperatively; vision remained stable in
four (after ≥5 follow-up visits), but did not improve. This study shows that tumor-related
optic neuropathy may be associated with marked visual loss inspite of successful tumor
resection; in 40% of children, the deterioration occurs perioperatively. Direct compression
is the main cause of visual loss, while papilledema usually resolved without visual seque-
lae. However, autoregulatory changes may be responsible for rapid visual loss following
decompression for chronic papilledema. Clinicians need reminding about the problem of
postoperative visual loss and we speculate on how it can be avoided.
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INTRODUCTION
There are three types of optic neuropathies caused by brain
tumors: compressive, papilledematous, and inﬁltrative. All can
lead to visual loss. The visual loss in compressive lesions is attrib-
uted to the interruption of the blood supply to the optic nerve
with secondary ischemic optic atrophy (Shehu and Tunau, 2005)
while papilledema may cause blockage of the axonal ﬂow (Stark
et al., 1999).
Brain tumors in children can be associated with visual loss
which may depend on the location, type of tumor, and dura-
tion of the disease. Posterior fossa tumors, which account for
about two-thirds of all brain tumors (Wilson, 1975; Stark et al.,
1999), are often associated with obstructive hydrocephalus and
prolonged papilledema. Supratentorial tumors that occupy the
suprasellar area (such as craniopharyngioma) directly compress
the optic nerve,butmay also cause hydrocephalus andpapilledema
(Wilson, 1975;Nguyen and Borruat, 2005; Gelb et al., 2008; Repka,
2010)Optic nerve gliomas invade the optic nerve tissue and impair
visual functions. Long-standing tumors, mainly due to delay in
diagnosis, may lead to more severe and less reversible visual loss.
Delayed diagnosis is more common in children because they
tend not to notice or complain of mild or unilateral reductions
in visual acuity (Stark et al., 1999; Defoort-Dhellemmes et al.,
2006).
The aim of the present study was to describe the visual results
of children with tumor-related visual disturbances after brain
surgery.
MATERIALS AND METHODS
The studywas approved by the local and nationalHumanResearch
Ethics Committees and was conducted in accordance with the
tenets of the Declaration of Helsinki.
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We reviewed the computerized database of the PediatricNeuro-
Ophthalmology Clinic of Schneider Children’s Medical Center of
Israel, a major tertiary facility, from 2003 to 2008 for all children
aged less than 16 years who sustained severe irreversible visual
loss due to tumor-related optic neuropathy with a follow-up of at
least 4months following surgical resection. Severe visual loss was
deﬁned as counting ﬁngers or less. Children with reversible visual
loss (optic neuritis) and reduced vision for reasons other than
isolated brain tumor-related optic nerve damage were excluded.
The following datawere collected from themedical ﬁles: patient
age at diagnosis and at last follow-up visit, gender, initial presenta-
tion, and symptoms of the underlying disease, date of diagnosis of
the underlying disease, ophthalmological and neuroimaging ﬁnd-
ings at diagnosis, after surgery, and at ﬁnal exam, cause of the optic
neuropathy, treatment of the underlying disease, and ophthal-
mological and neuroimaging ﬁndings at follow-up. In each visit
examination included best corrected visual acuity and a compre-
hensive Neuro-Ophthalmologic evaluation, according to patient’s
age and level of cooperation.
We compared the preoperative and postoperative results of the
individual patients on the vision tests to determine the time of
onset of the visual loss and changes in vision that occurred dur-
ing the course of the disease. The clinical data were evaluated to
identify possible precipitating factors.
RESULTS
During the 5-year study period, 240 children with a brain tumor
attended our clinic: optic pathway glioma was diagnosed in 62,
posterior fossa tumor in 117, craniopharyngioma in 30, and other
types in 31; 198 of them were operated. Fifteen children (15/198,
7.5%) had severe irreversible visual loss due to optic neuropa-
thy at the last follow-up visit. Five of them were excluded from
the present analysis: one died during surgery for craniopharyn-
gioma; one was lost to follow-up; and three, all of whom had huge
chiasmal and optic nerve gliomas, were too young to complete
the functional vision tests. The ﬁnal study group consisted of 10
children (5%), 5 boys and 5 girls of mean age 6.9± 2.7 years at
diagnosis (range 2.5–12 years) and 11.6± 5.0 years at ﬁnal exam-
ination (range 6.5–20 years). The mean duration of follow-up
was 5.0± 4.8 years (range 4months–16 years). The background
characteristics of the study group are shown in Table 1.
Ophthalmological data from the initial (preoperative) evalua-
tionwere available for 8 of the 10 children. The results of the vision
tests are shown in Table 2.
At diagnosis before surgery, one child had severe bilateral visual
loss (counting ﬁngers in the better eye); one had no light percep-
tion in one eye; one had no ﬁxation and failure to follow objects
in one eye; one had count ﬁnger only in one eye; three had 6/60 in
the worse eye; and only one had good vision (better than 6/10) in
both eyes.
Treatment of the tumor consisted of complete or partial
resection and shunting procedures for hydrocephalus (Table 3).
In the postoperative period, four children showed rapid severe
bilateral visual loss (Table 2). In the other six patients, all of whom
had impaired vision at presentation, visual acuity stabilized after
treatment of the tumor.
Table 1 | Background data at presentation of 10 patients with visual loss due to tumor-related optic neuropathy.
Pt. No. Gender/
age (year)*
Follow-up
(months)
Laterality* Tumor type Symptoms
(duration/months)
Signs
1 F/9.1 4+ B Post. fossa
astrocytoma
Headache, diplopia (2months) Esotropia, papilledema
2 M/6.2 8 B Post. fossa
meduloblastoma
Reduced vision, ataxia (2months) Reduced vision, papilledema
3 M/8 79 B Pineal germinoma Headache, reduced vision, hearing
loss (2months)
Reduced vision, Abnl. EOM
(Parinaud), papilledema
4 M/7.1 12 B Craniopharyngioma Diplopia, falls (0.5months) Reduced vision, papilledema
5 M/5 75 B Craniopharyngioma Headache Reduced vision, papilledema
6 F/5 48 B Craniopharyngioma Reduced vision, headache (3months) Reduced vision, exotropia, optic
atrophy
7 F/2.5 45 M Craniopharyngioma None Reduced vision, esotropia,
mono-nystagmus, papilledema
8 M/6 192 M Optic nerve glioma
‡
None (Strabismus since birth) Reduced vision, VF hemianopia,
optic atrophy
9 F/9 113 M Optic nerve glioma Headache, proptosis, reduced vision
(8months)
Reduced vision, VF hemianopia,
optic atrophy
10 F/12 26 M Optic nerve glioma Proptosis (1months) Proptosis, reduced vision, swollen
disk, CVO
Two children were totally asymptomatic at diagnosis. Seven of the eight symptomatic children had ocular symptoms already at presentation for the underlying disease.
These included blurred vision (n=4) with “bumping into objects” (in patient 3), diplopia (n=2), and proptosis (n=2).The diagnosis of the tumor was made on routine
examination in two patients, during neuroimaging for neuroﬁbromatosis type 1 in one patient, and during evaluation for new-onset strabismus, noted by the parents,
in one patient. CVO, central vein occlusion; EOM, extraocular movement; M, monocular; B, bilateral; VF, visual ﬁeld. *At presentation; +Parents refused follow-up;
‡Neuroﬁbromatosis.
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Table 3 |Treatment modalities.
Pt. no Tumor type Surgery Immediate surgical
complications
Shunt Postsurgical treatment
Chemotherapy/duration (years) Radiation
1 PF astrocytoma Resection Increased ICP blindness Yes No No
2 PF medulloblastoma Resection Increased ICP blindness Yes Yes (average risk) Craniospinal 54Gy/23.4Gy
3 Pineal germinoma Resection Parinaud synd.
decreased hearing and
vision
Yes VP16/carboplatin×1 (no further
chemotherapy)
Focal 45Gy
4 Craniophar. Resection DI No No No
5 Craniophar. Resection Pan-hypopit No No Focal 45Gy
6 Craniophar. Resection DI transient
hemiparesis
No No No
7 Craniophar. Resection None No No No
8 ON glioma Biopsy None No VCR/VP16 1.5 years No
9 ON glioma Biopsy None No VCR carboplatin 1.5 years
Velban 1.5 years
No
10 ON glioma Biopsy None No VCR/carboplatin 1 year Velban
1 year Temodar 0.5 year
Focal 54Gy
DI, diabetes insipidus; ICP, intracranial pressure; ON, optic nerve; Pan-hypopit, pan–hypopituitarism; PF, posterior fossa;VCR, vincristine; VP16, etoposide.
At the last follow-up visit, all patients had counting ﬁngers to no
light perception in at least one eye except for one patient severely
constricted visual ﬁeld in both eyes with acuity of 1/60. Optic
atrophy was detected bilaterally in nine children and unilaterally
in one.
Four children had bilateral visual loss after reduction of hydro-
cephalus (3/4) and tumor resection. Monocular visual loss was
detected in ﬁve (three optic nerve gliomas and two craniopharyn-
giomas).
DISCUSSION
We describe 10 children with brain tumor that have permanent
severe visual loss despite prompt treatment of the underlying
tumor. Of the 10, 9 had evidence of optic neuropathy at diag-
nosis before surgery. In four children, vision deteriorated rapidly
following tumor decompression for chronic papilledema; two
of them had posterior fossa tumors. The most common tumor
associated with persistent severe visual impairment was cranio-
pharyngioma located in the suprasellar region. Delayed diagnosis
and presentation with slowly progressive monocular visual loss
were characteristic of hypothalamic–chiasmic glioma.
The 10 childrenwith tumors and visual loss in the present study
represented 5% of the total number of children who attended
our center for treatment of brain tumors during the 5-year study
period (n = 198). Our search of the literature yielded no reports
on the incidence of rapid visual loss in children with brain tumors,
either at diagnosis or during surgical and adjuvant treatment.
Tumors of the posterior fossa are the most prevalent solid
brain tumors in children (Wilson, 1975; Dorner et al., 2007).
Although they are associated with hydrocephalus and papilledema
and delayed diagnosis, they rarely cause loss of vision (Dorner
et al., 2007). This ﬁnding suggests that increased ICP, even when
prolonged, is less dangerous in terms of visual loss than direct
compression, such as that induced by suprasellar tumors. Nev-
ertheless, two of the children in our cohort with posterior fossa
tumors exhibited rapid postoperative visual loss and immediate
pallor of the swollen disks following decompression.
Suprasellar tumors, by contrast, are associated with an 86%
rate of visual loss in adults (Chakrabarti et al., 2005; Kitthaweesin
and Ployprasith, 2008). In one study, one-third of patients with
ocular manifestations of brain tumors had craniopharyngiomas
(Kitthaweesin and Ployprasith, 2008). Reported rates of unilat-
eral or bilateral visual loss in patients with craniopharyngioma
were 3% of 68 patients (Chakrabarti et al., 2005) and 11.5% of
52 patients (Caldarelli et al., 2005). Our ﬁndings were compatible:
the four children with craniopharyngioma and visual loss in the
present cohort represented 13% of all children treated for cranio-
pharyngioma at our center (n = 30) during the study period. The
suggested mechanisms underlying the visual loss in patients with
craniopharyngiomas include direct pressure, increased ICP, and
papilledema.
The majority of children in this study with poor vision at
the end of the follow-up had reduced vision already at diagno-
sis. In a study of children with craniopharyngiomas, 33% had a
visual acuity of <6/60 in the better eye preoperatively (Defoort-
Dhellemmes et al., 2006); visual signs were present at diagnosis in
96% of patients, although only one-third were symptomatic. Half
the patients had loss of visual acuity at diagnosis, and about one-
third had papilledema (Defoort-Dhellemmes et al., 2006). Optic
nerve atrophywas detected in 38%at diagnosis.Abrams andRepka
(1997) described childrenwith tumors affecting the anterior visual
pathways, among whom 81% continued to lose vision with the
development of optic atrophy. They suggested that the chronic
progressive optic neuropathy was related to direct compression.
In the present study, the most impressive ﬁnding was the rapid
visual loss in the perioperative period in four patients (40%),
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of them three had papilledema and only one had direct tumor
pressure on the optic nerve, suggesting that in patients with
increased ICP, vision may deteriorate after rapid decompression
of the tumor. The fact that some children went blind following
surgery supports an association of visual loss with tumor removal.
In these cases, the mechanism may involve direct trauma to the
optic nerve/chiasm or its blood supply. Acute papilledema is rarely
associatedwith vision impairment, but long-standing papilledema
may cause irreversible visual loss in a minority of patients (Brew
et al., 1987). Local autoregulatory vascular changes and/or diver-
sion of the cerebral blood ﬂow into the ophthalmic circulation
may normalize blood supply to the optic nerve in the presence of
increased ICP (Querfurth et al., 2002; Cremer et al., 2004), and
therefore a rapid reduction in ICP could lead to immediate visual
impairment due to the new autoregulatory vascular levels. As in
the literature, we also suspect that the high susceptibility of the
optic nerve to interruption in the blood supply contributed to
the rapid visual loss (Roth and Barach, 2001; Sadda et al., 2001;
Dunker et al., 2002; Lee et al., 2006; Kaeser and Borruat, 2008;
Newman, 2008; Patil et al., 2008).
It is well known that early diagnosis and treatment are essen-
tial to preserve vision in tumor-related optic neuropathy, and that
recovery to normal levels is unlikely if profound loss of vision
continues for weeks to months (Stark et al., 1999). In children,
the problem is exacerbated because they often do not verbalize
unilateral visual loss (Defoort-Dhellemmes et al., 2006; Dorner
et al., 2007). Accordingly, in the present study, there was a large
discrepancy between the lack of visual complaints at diagnosis
and the ocular ﬁndings on routine eye examination. In another
study, approximately half the children were initially diagnosed
and treated for other diseases (Suharwardy and Elston, 1997;
Defoort-Dhellemmes et al., 2006; Dorner et al., 2007). Further-
more, given the possible association of visual deterioration with
the surgery itself, as shown here, clinicians should be aware
that in children, lack of awareness and poor cooperation dur-
ing vision tests, may mask a rapid visual loss following tumor
decompression.
This is a retrospective study, and only children with poor visual
outcome were included. The small number of actual patients in
the present study limits our conclusions. Brain tumors are well
known as an important cause of optic neuropathy with visual loss,
particularly suprasellar tumors such as craniopharyngioma and
glioma. Nevertheless, the ﬁndings clearly show that in spite of
successful tumor resection, children may loss vision immediately
after the operation regardless of the preoperative vision, type of
tumor or its location. The retrospective design of the study pre-
cluded identiﬁcation of parameters predicting perioperative visual
loss. Therefore, our general recommendation is to carefully mon-
itor ICP reduction and visual function in all children with brain
tumors and papilledema.
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